PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
ATAC 239 Target Disease Breast Cancer 173,695 144 0.02 -0.63 0.60 0.65
ERBB4 994 Target Target ERBB3 1,154 394 0.37 -0.63 0.40 0.91
Adenosine Deaminase 6,613 Target Target ADAT1 5 3 0.02 -0.63 0.60 0.69
CEA 17,022 Target Target CA 72-4 184 108 0.06 -0.64 0.59 0.72
ERK1 18,374 Target Target ERK2 3,287 1,788 0.23 -0.64 0.54 0.82
DDR2 194 Target Target Collagen 138,882 113 0.02 -0.65 0.58 0.65
CA125 Antigen 78 Target Disease Ovarian Cancer 33,996 45 0.03 -0.65 0.58 0.68
EPHB3 118 Target Target EPHB2 385 59 0.28 -0.65 0.50 0.88
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
Epidermal Growth Factor Receptor 24,772 Target Disease Cancer 1,053,491 13,587 0.08 -0.67 0.55 0.66
CHK2 1,391 Target Target CHK1 2,044 533 0.32 -0.68 0.38 0.89
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Cancer 1,053,491 21 0.00 -0.68 0.54 0.58
Cytokeratin 20 847 Target Disease Carcinoma 433,099 449 0.02 -0.69 0.53 0.63
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
Epigen 27 Target Target EGF 27,487 14 0.02 -0.69 0.52 0.67
Erbb2 4,536 Target Target ERBB4 994 461 0.22 -0.69 0.46 0.83
CCL5 2,002 Target Target CCL3 1,427 500 0.30 -0.70 0.35 0.89
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
Alpha-Glucosidase 4,319 Target Drug Alglucosidase Alfa (Myozyme)- FDA 4 2 0.02 -0.71 0.50 0.69
Alpha-Glucosidase 4,319 Target Drug Alglucosidase Alfa (Lumizyme)- FDA 1 1 0.02 -0.71 1.00 0.69
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target C1orf41 1 1 0.01 -0.71 1.00 0.68
BNP 6,842 Target Target BNP/NPPB 1 1 0.01 -0.71 1.00 0.68
C7 7,027 Target Drug Kadangustin J 2 1 0.01 -0.71 0.50 0.67
Myeloperoxidase 16,181 Target Drug Azithromycin (Zithromax Injection)- FDA 1 1 0.01 -0.71 1.00 0.66
Renin 43,456 Target Disease Hypertension (High Blood Pressure) 2 1 0.00 -0.71 0.50 0.62
Atp-Binding Cassette Sub-Family G Member 1 2 Target Disease Liver Disease 49,817 1 0.00 -0.71 0.50 0.62
CD4 112,219 Target Target Ck-beta-11 4 2 0.00 -0.71 0.50 0.61
EoCP-1 1 Target Disease Asthma 109,610 1 0.00 -0.71 1.00 0.61
CD4 112,219 Target Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.60
CD4 112,219 Target Disease Infection Upper Respiratory Tract 1 1 0.00 -0.71 1.00 0.61
Adp/Atp Translocase 3 2 Target Disease Breast Cancer 173,695 1 0.00 -0.71 0.50 0.60
CSF2/GM-CSF 2 Target Disease Infection 766,637 1 0.00 -0.71 0.50 0.57
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
CCL2 3,560 Target Target CCL3 1,427 533 0.24 -0.73 0.37 0.85
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
CCL5 2,002 Target Target CCL2 3,560 673 0.25 -0.73 0.34 0.87
Retinoic Acid Receptor Alpha 1,068 Target Disease Leukemia 162,805 490 0.04 -0.73 0.46 0.66
CCL7 274 Target Target CCL8 197 60 0.26 -0.74 0.30 0.90
Vascular Cell Adhesion Protein 1 31 Target Disease Inflammation 252,734 14 0.01 -0.74 0.45 0.60
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CINC-2- alpha 9 Target Disease Inflammation 252,734 4 0.00 -0.75 0.44 0.59
BAFF 1,240 Target Target BLyS 457 164 0.22 -0.75 0.36 0.86
CCL4 5,638 Target Target CCL3 1,427 535 0.19 -0.75 0.37 0.83